Recombinant Human Follistatin-like 1 Protein, CF

Catalog # Availability Size / Price Qty
1694-FN-050
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (5)
FAQs
Supplemental Products
Reviews

Recombinant Human Follistatin-like 1 Protein, CF Summary

Product Specifications

Endotoxin Level
<0.100 EU per 1 µg of the protein by the LAL method.
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human Follistatin‑like 1/FSTL1 is coated at 2 μg/mL (100 μL/well), the concentration of recombinant human BMP-4 that produces 50% of the optimal binding response is found to be approximately 10-60 ng/mL.

Accession #
N-terminal Sequence
Analysis
Glu21
Predicted Molecular Mass
36.4 kDa
SDS-PAGE
45-50 kDa, reducing conditions

Product Datasheets

You must select a language.

x

1694-FN

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

1694-FN

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 200 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Follistatin-like 1/FSTL1

Follistatin‑like 1 (FSL1 or FSTL1), also known as FRP (follistatin‑related protein), Flik (follistatin‑like), and TSC‑36 (TGF‑ beta 1‑stimulated clone 36), is a secreted 45‑55 kDa extracellular glycoprotein belonging to the BM‑40/SPARC/Osteonectin family (1‑3). The human FSL‑1 cDNA encodes 308 amino acids (aa), including a 20 aa signal sequence, a cysteine‑rich Follistatin (EGF- and kazal‑like) domain, two apparently non‑functional EF‑hand calcium‑binding motifs, and a von Willebrand Factor C homology domain (1, 3). Mature human FSL1 shares 94%, 95%, 98% and 99% aa identity with mouse, rat, bovine and equine FSL1, respectively. FSL1 was first identified as a TGF‑ beta ‑induced protein from a mouse osteoblast cell line (4). It is ubiquitously expressed in early mouse development, but is mainly mesenchymal later in development (5). In vitro, FSTL1 interacts directly with BMP‑4, while in vivo, it regulates BMP‑4 signaling during normal lung development, as demonstrated by lethal respiratory failure in mice deleted for FSTL1 (6). In humans, FSL1 is a common rheumatoid arthritis auto‑antigen (2). It is reported to be either pro‑inflammatory due to promoting inflammatory cytokine secretion, or to prevent autoimmune arthritis by inhibiting matrix metalloproteinase (MMP) and prostaglandin expression (7‑10). In muscle and heart, it appears to be protective and promotes endothelial cell functions such as revascularization after ischemia, probably due to promoting expression and activation of the protein kinase AKT1 (11, 12). Cardiac and circulating FSL1 is generally increased in conditions such as heart failure and acute coronary syndrome (12‑14). FSL1 also appears to be a tumor suppressor, showing down‑regulated expression in many human cancers (4, 15, 16). In vitro, it slows proliferation and MMP‑dependent migration, and increases FAS‑dependent apoptosis of tumor cell lines (15).

References
  1. Zwijsen, A. et al. (1994) Eur. J. Biochem. 225:937.
  2. Tanaka, M. et al. (1998) Int. Immunol. 10:1305.
  3. Hambrook, H.O. et al. (2004) J. Biol. Chem. 279:11727.
  4. Shibanuma, M. et al. (1993) Eur. J. Biochem. 217:13.
  5. Adams, D. et al. (2007) Gene Expr. Patterns 7:491.
  6. Geng, Y et al. (2011) Proc. Natl. Acad. Sci. USA 108:7058.
  7. Clutter, S.D. et al. (2009) J. Immunol. 182:234.
  8. Miyamae, T. et al. (2006) J. Immunol. 177:4758.
  9. Kawabata, D. et al. (2004) Arthritis Rheum. 50:660.
  10. Tanaka, M. et al. (2003) Int. Immunol. 15:71.
  11. Ouchi, N. et al. (2008) J. Biol. Chem. 283:32802.
  12. Oshima, Y. et al. (2008) Circulation 117:3099.
  13. Lara-Pezzi, E. et al. (2008) Endocrinology 149:5822.
  14. Widera, C. et al. (2009) Clin. Chem. 55:1794.
  15. Chan, Q.K. et al. (2009) Carcinogenesis 30:114.
  16. Mashimo, J. et al. (1997) Cancer Lett. 113:213.
  17.  
Entrez Gene IDs
11167 (Human); 14314 (Mouse); 79210 (Rat)
Alternate Names
Flik; FLJ50214; Follistatin-like 1; Follistatin-like protein 1; follistatin-related protein 1; Follistatin-related Protein; FRP; FRPFLJ52277; FSL1; FSTL1; TSC-36

Citations for Recombinant Human Follistatin-like 1 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

5 Citations: Showing 1 - 5
Filter your results:

Filter by:

  1. Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/beta-catenin signaling in obstructed kidneys in vivo
    Authors: Y Zhang, Y Wang, G Zheng, Y Liu, J Li, H Huang, C Xu, Y Zeng, X Zhang, J Qin, C Dai, HO Hambrock, U Hartmann, B Feng, KK Mak, Y Liu, HY Lan, Y Huang, ZH Zheng, Y Xia
    The Journal of Biological Chemistry, 2022-05-04;0(0):102010.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Cell Culture
  2. FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival
    Authors: M Wu, Y Ding, N Wu, J Jiang, Y Huang, F Zhang, H Wang, Q Zhou, Y Yang, W Zhuo, L Teng
    American journal of cancer research, 2021-03-01;11(3):712-728.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice
    Authors: W Zhang, W Wang, J Liu, J Li, J Wang, Y Zhang, Z Zhang, Y Liu, Y Jin, J Li, J Cao, C Wang, W Ning, J Wang
    Sci Rep, 2017-03-31;7(0):45820.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  4. A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth
    Sci Rep, 2016-11-25;6(0):37839.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.
    Authors: Wei K, Serpooshan V, Hurtado C, Diez-Cunado M, Zhao M, Maruyama S, Zhu W, Fajardo G, Noseda M, Nakamura K, Tian X, Liu Q, Wang A, Matsuura Y, Bushway P, Cai W, Savchenko A, Mahmoudi M, Schneider M, van den Hoff M, Butte M, Yang P, Walsh K, Zhou B, Bernstein D, Mercola M, Ruiz-Lozano P
    Nature, 2015-09-16;525(7570):479-85.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human Follistatin-like 1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Follistatin-like 1 Protein, CF and earn rewards!

Have you used Recombinant Human Follistatin-like 1 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review